{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:39:18Z","timestamp":1779907158609,"version":"3.53.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.nucmedbio.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T21:07:58Z","timestamp":1504213678000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV"],"prefix":"10.1016","volume":"55","author":[{"given":"Sanhita","family":"Sinharay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios Z.","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Maric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima A.","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nucmedbio.2017.08.004_bb0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"},{"issue":"23","key":"10.1016\/j.nucmedbio.2017.08.004_bb0010","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/11597770-000000000-00000","article-title":"HIV-associated neurological disorders: a guide to pharmacotherapy","volume":"26","author":"Tan","year":"2012","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/026988110001400305","article-title":"Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia","volume":"14","author":"Nath","year":"2000","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.56.2.278","article-title":"Parkinsonism as the presenting manifestation of HIV infection: improvement on HAART","volume":"56","author":"Hersh","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nucmedbio.2017.08.004_bb0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s007020170051","article-title":"Neurotransmission in HIV associated dementia: a short review","volume":"108","author":"Koutsilieri","year":"2001","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0035","first-page":"184","article-title":"Dopamine systems in human immunodeficiency virus-associated dementia","volume":"12","author":"Lopez","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2017.08.004_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.870130413","article-title":"Parkinsonism with HIV infection","volume":"13","author":"Mirsattari","year":"1998","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11481-009-9160-8","article-title":"Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat","volume":"4","author":"Liu","year":"2009","journal-title":"J NeuroImmune Pharmacol"},{"issue":"5","key":"10.1016\/j.nucmedbio.2017.08.004_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/157016212802138788","article-title":"Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge","volume":"10","author":"Moran","year":"2012","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.nucmedbio.2017.08.004_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.expneurol.2012.10.008","article-title":"Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction","volume":"239","author":"Moran","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nucmedbio.2017.08.004_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2016.01.022","article-title":"Characterization of neuropathology in the HIV-1 transgenic rat at different ages","volume":"292","author":"Reid","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/13550281003690177","article-title":"Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat","volume":"16","author":"Webb","year":"2010","journal-title":"J Neurovirol"},{"issue":"16","key":"10.1016\/j.nucmedbio.2017.08.004_bb0070","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1073\/pnas.161290298","article-title":"An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction","volume":"98","author":"Reid","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.nucmedbio.2017.08.004_bb0075","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s11481-013-9472-6","article-title":"Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat","volume":"8","author":"Moran","year":"2013","journal-title":"J NeuroImmune Pharmacol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2017.08.004_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13550280802232996","article-title":"Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat","volume":"15","author":"Lashomb","year":"2009","journal-title":"J Neurovirol"},{"issue":"1-2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2009.09.014","article-title":"The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART","volume":"218","author":"Peng","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nucmedbio.2017.08.004_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbi.2015.02.020","article-title":"The HIV-1 transgenic rat model of neuroHIV","volume":"48","author":"Vigorito","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0095","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0169-328X(94)90227-5","article-title":"Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies","volume":"23","author":"Bal","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"issue":"9","key":"10.1016\/j.nucmedbio.2017.08.004_bb0100","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1073\/pnas.011538198","article-title":"Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A","volume":"98","author":"Lin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2478\/v10134-010-0035-6","article-title":"Astrocyte expression of D2-like dopamine receptors in the prefrontal cortex","volume":"1","author":"Mladinov","year":"2010","journal-title":"Transl Neurosci"},{"issue":"4","key":"10.1016\/j.nucmedbio.2017.08.004_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/glia.22449","article-title":"Dopamine D3 receptor activation promotes neural stem\/progenitor cell proliferation through AKT and ERK1\/2 pathways and expands type-B and -C cells in adult subventricular zone","volume":"61","author":"Lao","year":"2013","journal-title":"Glia"},{"issue":"Pt A","key":"10.1016\/j.nucmedbio.2017.08.004_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuropharm.2016.09.028","article-title":"Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease","volume":"113","author":"Elgueta","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.nucmedbio.2017.08.004_bb0120","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/jcbfm.2014.63","article-title":"Radiosynthesis and validation of (1)(8)F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain","volume":"34","author":"Cumming","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1-2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2004.11.005","article-title":"Measurement of d-amphetamine-induced effects on the binding of dopamine D-2\/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET","volume":"1032","author":"Mukherjee","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2017.08.004_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2014.00031","article-title":"Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV","volume":"13","author":"Lee","year":"2014","journal-title":"Mol Imaging"},{"issue":"6","key":"10.1016\/j.nucmedbio.2017.08.004_bb0135","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00004647-200006000-00002","article-title":"Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907","volume":"20","author":"Watabe","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3 Pt 1","key":"10.1016\/j.nucmedbio.2017.08.004_bb0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"NeuroImage"},{"issue":"1-2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2012.03.015","article-title":"Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat","volume":"247","author":"Royal","year":"2012","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuro.2005.10.003","article-title":"Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor","volume":"27","author":"Aksenov","year":"2006","journal-title":"Neurotoxicology"},{"issue":"5-6","key":"10.1016\/j.nucmedbio.2017.08.004_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/13550280903296346","article-title":"Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage","volume":"15","author":"Hu","year":"2009","journal-title":"J Neurovirol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03033922","article-title":"Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons","volume":"12","author":"Mocchetti","year":"2007","journal-title":"Neurotox Res"},{"issue":"4","key":"10.1016\/j.nucmedbio.2017.08.004_bb0165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pbb.2011.03.013","article-title":"Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats","volume":"98","author":"Midde","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.nucmedbio.2017.08.004_bb0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/0929867322666150311164504","article-title":"Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine","volume":"13","author":"Wayman","year":"2015","journal-title":"Curr HIV Res"},{"issue":"Pt 11","key":"10.1016\/j.nucmedbio.2017.08.004_bb0175","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/brain\/awh269","article-title":"Decreased brain dopaminergic transporters in HIV-associated dementia patients","volume":"127","author":"Wang","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0180","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroimage.2008.05.011","article-title":"Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse","volume":"42","author":"Chang","year":"2008","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.nucmedbio.2017.08.004_bb0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0306-4522(98)00284-X","article-title":"D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro","volume":"89","author":"Wong","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2017.08.004_bb0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2015.09.012","article-title":"Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis","volume":"275","author":"Meeker","year":"2015","journal-title":"Exp Neurol"},{"issue":"24","key":"10.1016\/j.nucmedbio.2017.08.004_bb0195","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1111\/bph.12875","article-title":"Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV- neurotoxicity: potential for drug repositioning for the treatment of neurodegenerative disorders","volume":"171","author":"Wrasidlo","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2017.08.004_bb0200","doi-asserted-by":"crossref","first-page":"e77577","DOI":"10.1371\/journal.pone.0077577","article-title":"CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nucmedbio.2017.08.004_bb0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11481-012-9381-0","article-title":"Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat","volume":"7","author":"Ramadan","year":"2012","journal-title":"J NeuroImmune Pharmacol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2017.08.004_bb0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.nbd.2011.10.005","article-title":"HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes","volume":"45","author":"Agrawal","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.nucmedbio.2017.08.004_bb0215","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/aid.2009.0065","article-title":"Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia","volume":"25","author":"Heron","year":"2009","journal-title":"AIDS Res Hum Retrovir"},{"issue":"14","key":"10.1016\/j.nucmedbio.2017.08.004_bb0220","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.nucmedbio.2017.08.004_bb0225","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/j.1460-9568.2007.05506.x","article-title":"Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo","volume":"25","author":"Nosheny","year":"2007","journal-title":"Eur J Neurosci"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117301786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117301786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:37:48Z","timestamp":1719419868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805117301786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"alternative-id":["S0969805117301786"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.08.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}